30
Participants
Start Date
August 31, 2019
Primary Completion Date
January 31, 2021
Study Completion Date
March 31, 2021
Evolocumab Auto-Injector [Repatha]
Evolocumab 140 mg every 2 weeks for 12 weeks
Placebos
Placebo subcutaneous injection every 2 weeks for 12 weeks
Collaborators (1)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
OTHER
Erasmus Medical Center
OTHER
University Medical Center Nijmegen
OTHER
UMC Utrecht
OTHER